If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCanal+ Regulatory News (CAN)

Share Price Information for Canal+ (CAN)

Share Price is delayed by 15 minutes
Get Live Data
262.60    4.20 (1.63%)
Bid:
258.20
Ask:
262.00
Spread: 3.80 (1.472%)
Market Cap: £2.57b
CAN Live PriceLast checked at - London Stock Exchange

Intraday Canal+ Share Chart

Holding(s) in Company

17 Jun 2010 14:00

RNS Number : 8037N
Central African Gold PLC
17 June 2010
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Central African Gold Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

3. Full name of person(s) subject to the notification obligation: iii

HBD Zim Investments Limited

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

16 June 2010

6. Date on which issuer notified:

17 June 2010

7. Threshold(s) that is/are crossed or reached: vi, vii

Less than 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Share

282,985,496

282,985,496

0

0

0

0

0

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

0

0

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Vic Ferns

15. Contact telephone number:

+44 1624 643643 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBVURRAANAAR
Date   Source Headline
8th Jun 20268:00 amRNSDIVIDEND CURRENCY CONVERSION ANNOUNCEMENT
2nd Jun 20269:26 amRNSHolding(s) in Company
1st Jun 20265:27 pmRNSAPPOINTMENTS TO THE SUPERVISORY BOARD
29th May 20266:07 pmRNSResults of Combined Shareholders' General Meeting
27th May 20263:00 pmRNSHolding(s) in Company
18th May 20266:28 pmRNSPublication of the Final Information Memorandum
13th May 20266:28 pmRNS€700 MILLION BOND ISSUE SUCCESSFULLY PRICED
13th May 20264:00 pmRNSStabilisation Notice- CANAL+
13th May 20263:37 pmRNSConvening Brochure - Shareholders’ General Meeting
13th May 20268:58 amRNSStabilisation Notice- CANAL +
12th May 20265:17 pmRNSHolding(s) in Company
12th May 20267:05 amRNSSECONDARY INWARD LISTING ON THE JSE
11th May 20269:23 amRNSPOTENTIAL BOND TRANSACTION
28th Apr 20267:00 amRNSCANAL+ Q1 2026 Trading Update
17th Apr 20261:05 pmRNSDirector Declaration
20th Mar 20263:38 pmRNSDirector/PDMR Shareholding
17th Mar 20263:28 pmRNSDirector/PDMR Shareholding
17th Mar 20263:26 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSAnnual Financial Report
17th Mar 20267:00 amRNSAnnual Financial Report
12th Mar 20264:14 pmRNSDirector/PDMR Shareholding
12th Mar 20264:11 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNS2025 FY Preliminary Results & Strategic Update
11th Mar 20267:00 amRNS2025 FY Preliminary Results & Strategic Update
5th Mar 20267:10 amRNSMCG RETIRES SHOWMAX AFTER COMPREHENSIVE REVIEW
27th Feb 20261:22 pmRNSDirector Declaration
12th Feb 20263:47 pmRNSHolding(s) in Company
11th Feb 20263:06 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSCANAL+ MULTICHOICE SYNERGIES UPDATE
28th Jan 20262:42 pmRNSHolding(s) in Company
26th Jan 20269:09 amRNSDate of communication on MCG acquisition synergies
23rd Jan 20264:44 pmRNSHolding(s) in Company
6th Jan 20264:02 pmRNSHolding(s) in Company
2nd Jan 20262:43 pmRNSHolding(s) in Company
2nd Jan 202610:40 amRNSHolding(s) in Company
2nd Jan 202610:37 amRNSHolding(s) in Company
2nd Jan 202610:09 amRNSTotal Voting Rights
19th Dec 202510:30 amRNSRESOLUTION OF FRENCH VAT DISPUTE
19th Dec 202510:30 amRNSRESOLUTION OF FRENCH VAT DISPUTE
18th Dec 20255:00 pmRNSSUCCESSFUL EUR 1.8 BILLION FINANCING AGREEMENT
18th Dec 20255:00 pmRNSSUCCESSFUL EUR 1.8 BILLION FINANCING AGREEMENT
11th Dec 20252:24 pmRNSPost-Stabilisation Notice- Canal +
8th Dec 20252:15 pmRNSTERMINATION OF MULTICHOICE JSE AND A2X LISTINGS
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:34 pmRNSPUBLICATION OF THE FINAL INFORMATION MEMORANDUM
1st Dec 20252:13 pmRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20255:21 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNS€700 MILLION BOND ISSUE SUCCESSFULLY PRICED

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.